KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 77 filers reported holding KYMERA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $705,912 | -33.5% | 50,785 | +10.0% | 0.00% | -50.0% |
| Q2 2023 | $1,061,885 | +327.7% | 46,189 | +451.2% | 0.00% | +300.0% |
| Q1 2023 | $248,270 | -63.2% | 8,379 | -69.0% | 0.00% | -75.0% |
| Q4 2022 | $673,970 | -56.6% | 27,002 | -62.2% | 0.00% | -55.6% |
| Q3 2022 | $1,554,000 | +144.0% | 71,372 | +443.0% | 0.01% | +28.6% |
| Q2 2021 | $637,000 | +157.9% | 13,143 | +71.6% | 0.01% | +75.0% |
| Q3 2020 | $247,000 | – | 7,658 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer IX & Co. Ltd. | 1,755,356 | $97,949,000 | 48.97% |
| Trustees of Columbia University in the City of New York | 463,298 | $28,724,000 | 38.38% |
| AJU IB Investment Co., Ltd. | 704,059 | $43,652,000 | 16.52% |
| BVF INC/IL | 2,630,658 | $163,101,000 | 6.42% |
| Redmile Group, LLC | 2,720,489 | $168,670,000 | 2.04% |
| Bain Capital Life Sciences Investors, LLC | 479,605 | $29,735,000 | 1.87% |
| Rock Springs Capital Management LP | 713,865 | $44,260,000 | 0.94% |
| SPHERA FUNDS MANAGEMENT LTD. | 147,700 | $9,157,000 | 0.81% |
| HighVista Strategies LLC | 17,117 | $1,061,000 | 0.68% |
| Logos Global Management LP | 110,920 | $6,877,000 | 0.59% |